Neoadjuvant chemotherapy followed by surgical cytoreduction in advanced epithelial ovarian cancer

Abstract

NACT followed by surgical cytoreduction is a promising treatment strategy for the management of advanced epithelial ovarian cancers. A significant number of patients exhibit response to NACT. Downstaging following NACT leads to higher optimal cytoreduction rates and improved survival in comparison to historical controls.